APO Research
Talk to an analyst

APO RESEARCH · REPORT

Acellular DTP Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Acellular DTP Vaccine Industry Growth and Trends Forecast to 2032

28 December 202593 pages

Choose your research edition.

Industry ResearchAcellular DTP Vaccine Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Acellular DTP Vaccine Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Acellular DTP Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Acellular DTP Vaccine Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Acellular DTP Vaccine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Acellular DTP Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Acellular DTP Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Acellular DTP Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Acellular DTP Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Acellular DTP Vaccine include AJ Vaccines, GSK, Panacea Biotec, Sanofi, Hualan Biological Vaccine, BioKangtai, CanSino Biologics, Walvax Biotechnology and CNBG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Acellular DTP Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Acellular DTP Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Acellular DTP Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Acellular DTP Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Acellular DTP Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Acellular DTP Vaccine Market by Company

AJ Vaccines

GSK

Panacea Biotec

Sanofi

Hualan Biological Vaccine

BioKangtai

CanSino Biologics

Walvax Biotechnology

CNBG

Acellular DTP Vaccine Segment by Type

Co-purified DTP Vaccine

Component DTP Vaccine

Acellular DTP Vaccine Segment by Application

Adults

Children

Acellular DTP Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acellular DTP Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Acellular DTP Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acellular DTP Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Acellular DTP Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Acellular DTP Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Co-purified DTP Vaccine Table 2. Major Company of Component DTP Vaccine Table 3. Global Acellular DTP Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Acellular DTP Vaccine Sales by Type (2021-2026) & (K Units) Table 5. Global Acellular DTP Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Acellular DTP Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Acellular DTP Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Acellular DTP Vaccine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Acellular DTP Vaccine Sales by Type (2027-2032) & (K Units) Table 10. Global Acellular DTP Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Acellular DTP Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Acellular DTP Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Acellular DTP Vaccine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Acellular DTP Vaccine Sales by Type (2021-2026) & (K Units) Table 15. North America Acellular DTP Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Acellular DTP Vaccine Sales by Type (2021-2026) & (K Units) Table 17. Europe Acellular DTP Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Acellular DTP Vaccine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Acellular DTP Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Acellular DTP Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Acellular DTP Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Acellular DTP Vaccine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Acellular DTP Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Acellular DTP Vaccine Industry Trends Table 25. Acellular DTP Vaccine Industry Drivers Table 26. Acellular DTP Vaccine Industry Opportunities and Challenges Table 27. Acellular DTP Vaccine Industry Restraints Table 28. Global Acellular DTP Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Acellular DTP Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Acellular DTP Vaccine Sales by Company (2021-2026) & (K Units) Table 31. Global Acellular DTP Vaccine Sales Share by Company (2021-2026) Table 32. Global Acellular DTP Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Acellular DTP Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Acellular DTP Vaccine Major Company Production Sites and Headquarters Table 35. Global Acellular DTP Vaccine Company, Product Type & Application Table 36. Global Acellular DTP Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Acellular DTP Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Acellular DTP Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Acellular DTP Vaccine Sales by Region (2021-2026) & (K Units) Table 41. Global Acellular DTP Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Acellular DTP Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Acellular DTP Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Acellular DTP Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Acellular DTP Vaccine Sales by Region (2027-2032) & (K Units) Table 46. Global Acellular DTP Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Acellular DTP Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Acellular DTP Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Acellular DTP Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Acellular DTP Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Acellular DTP Vaccine Sales by Application (2021-2026) & (K Units) Table 52. Global Acellular DTP Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Acellular DTP Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Acellular DTP Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Acellular DTP Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Acellular DTP Vaccine Sales by Application (2027-2032) & (K Units) Table 57. Global Acellular DTP Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Acellular DTP Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Acellular DTP Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Acellular DTP Vaccine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Acellular DTP Vaccine Sales by Application (2021-2026) & (K Units) Table 62. North America Acellular DTP Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Acellular DTP Vaccine Sales by Application (2021-2026) & (K Units) Table 64. Europe Acellular DTP Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Acellular DTP Vaccine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Acellular DTP Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Acellular DTP Vaccine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Acellular DTP Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Acellular DTP Vaccine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Acellular DTP Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. AJ Vaccines Company Information Table 72. AJ Vaccines Business Overview Table 73. AJ Vaccines Acellular DTP Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. AJ Vaccines Acellular DTP Vaccine Product Portfolio Table 75. AJ Vaccines Recent Development Table 76. GSK Company Information Table 77. GSK Business Overview Table 78. GSK Acellular DTP Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. GSK Acellular DTP Vaccine Product Portfolio Table 80. GSK Recent Development Table 81. Panacea Biotec Company Information Table 82. Panacea Biotec Business Overview Table 83. Panacea Biotec Acellular DTP Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Panacea Biotec Acellular DTP Vaccine Product Portfolio Table 85. Panacea Biotec Recent Development Table 86. Sanofi Company Information Table 87. Sanofi Business Overview Table 88. Sanofi Acellular DTP Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Sanofi Acellular DTP Vaccine Product Portfolio Table 90. Sanofi Recent Development Table 91. Hualan Biological Vaccine Company Information Table 92. Hualan Biological Vaccine Business Overview Table 93. Hualan Biological Vaccine Acellular DTP Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Hualan Biological Vaccine Acellular DTP Vaccine Product Portfolio Table 95. Hualan Biological Vaccine Recent Development Table 96. BioKangtai Company Information Table 97. BioKangtai Business Overview Table 98. BioKangtai Acellular DTP Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. BioKangtai Acellular DTP Vaccine Product Portfolio Table 100. BioKangtai Recent Development Table 101. CanSino Biologics Company Information Table 102. CanSino Biologics Business Overview Table 103. CanSino Biologics Acellular DTP Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. CanSino Biologics Acellular DTP Vaccine Product Portfolio Table 105. CanSino Biologics Recent Development Table 106. Walvax Biotechnology Company Information Table 107. Walvax Biotechnology Business Overview Table 108. Walvax Biotechnology Acellular DTP Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Walvax Biotechnology Acellular DTP Vaccine Product Portfolio Table 110. Walvax Biotechnology Recent Development Table 111. CNBG Company Information Table 112. CNBG Business Overview Table 113. CNBG Acellular DTP Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. CNBG Acellular DTP Vaccine Product Portfolio Table 115. CNBG Recent Development Table 116. North America Acellular DTP Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. North America Acellular DTP Vaccine Sales by Country (2021-2026) & (K Units) Table 118. North America Acellular DTP Vaccine Sales Market Share by Country (2021-2026) Table 119. North America Acellular DTP Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 120. North America Acellular DTP Vaccine Sales Market Share Forecast by Country (2027-2032) Table 121. North America Acellular DTP Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Acellular DTP Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Acellular DTP Vaccine Market Share by Country (2021-2026) Table 124. North America Acellular DTP Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Acellular DTP Vaccine Market Share Forecast by Country (2027-2032) Table 126. Europe Acellular DTP Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Europe Acellular DTP Vaccine Sales by Country (2021-2026) & (K Units) Table 128. Europe Acellular DTP Vaccine Sales Market Share by Country (2021-2026) Table 129. Europe Acellular DTP Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 130. Europe Acellular DTP Vaccine Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Acellular DTP Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Acellular DTP Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Acellular DTP Vaccine Market Share by Country (2021-2026) Table 134. Europe Acellular DTP Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Acellular DTP Vaccine Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Acellular DTP Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Acellular DTP Vaccine Sales by Country (2021-2026) & (K Units) Table 138. Asia-Pacific Acellular DTP Vaccine Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Acellular DTP Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 140. Asia-Pacific Acellular DTP Vaccine Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Acellular DTP Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Acellular DTP Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Acellular DTP Vaccine Market Share by Country (2021-2026) Table 144. Asia-Pacific Acellular DTP Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Acellular DTP Vaccine Market Share Forecast by Country (2027-2032) Table 146. Latin America Acellular DTP Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Latin America Acellular DTP Vaccine Sales by Country (2021-2026) & (K Units) Table 148. Latin America Acellular DTP Vaccine Sales Market Share by Country (2021-2026) Table 149. Latin America Acellular DTP Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 150. Latin America Acellular DTP Vaccine Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Acellular DTP Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Acellular DTP Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Acellular DTP Vaccine Market Share by Country (2021-2026) Table 154. Latin America Acellular DTP Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Acellular DTP Vaccine Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Acellular DTP Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Acellular DTP Vaccine Sales by Country (2021-2026) & (K Units) Table 158. Middle East and Africa Acellular DTP Vaccine Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Acellular DTP Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 160. Middle East and Africa Acellular DTP Vaccine Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Acellular DTP Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Acellular DTP Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Acellular DTP Vaccine Market Share by Country (2021-2026) Table 164. Middle East and Africa Acellular DTP Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Acellular DTP Vaccine Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Acellular DTP Vaccine Distributors List Table 169. Acellular DTP Vaccine Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Acellular DTP Vaccine Image Figure 2. Global Acellular DTP Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Acellular DTP Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Acellular DTP Vaccine Sales (2021-2032) & (K Units) Figure 5. Co-purified DTP Vaccine Image Figure 6. Global Co-purified DTP Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 7. Component DTP Vaccine Image Figure 8. Global Component DTP Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Acellular DTP Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Acellular DTP Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Acellular DTP Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Acellular DTP Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Acellular DTP Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Acellular DTP Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Acellular DTP Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Acellular DTP Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Acellular DTP Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Acellular DTP Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Acellular DTP Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Acellular DTP Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Acellular DTP Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Adults Image Figure 24. Global Adults Sales YoY Growth (2021-2032) & (K Units) Figure 25. Children Image Figure 26. Global Children Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Acellular DTP Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Acellular DTP Vaccine Market Share by Application 2025 VS 2032 Figure 29. North America Acellular DTP Vaccine Sales Market Share in Volume by Application in 2025 Figure 30. North America Acellular DTP Vaccine Sales Market Share in Value by Application in 2025 Figure 31. Europe Acellular DTP Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Acellular DTP Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Acellular DTP Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Acellular DTP Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Acellular DTP Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Acellular DTP Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Acellular DTP Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Acellular DTP Vaccine Sales Market Share in Value by Application in 2025 Figure 39. North America Acellular DTP Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Acellular DTP Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Acellular DTP Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Acellular DTP Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Acellular DTP Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Acellular DTP Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Acellular DTP Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Acellular DTP Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Acellular DTP Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Acellular DTP Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Acellular DTP Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Acellular DTP Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Acellular DTP Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Acellular DTP Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Acellular DTP Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Acellular DTP Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Acellular DTP Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Acellular DTP Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Acellular DTP Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Acellular DTP Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Acellular DTP Vaccine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Acellular DTP Vaccine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Co-purified DTP Vaccine
  • Component DTP Vaccine
Applications
  • Adults
  • Children
Companies covered
  • AJ Vaccines
  • GSK
  • Panacea Biotec
  • Sanofi
  • Hualan Biological Vaccine
  • BioKangtai
  • CanSino Biologics
  • Walvax Biotechnology
  • CNBG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Acellular DTP Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Acellular DTP Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Acellular DTP Vaccine Market by Type
  6. 1.3.1 Co-purified DTP Vaccine
  7. 1.3.2 Component DTP Vaccine
  8. 1.4 Global Acellular DTP Vaccine Market Size by Type
  9. 1.4.1 Global Acellular DTP Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Acellular DTP Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Acellular DTP Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Acellular DTP Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Acellular DTP Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Acellular DTP Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Acellular DTP Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Acellular DTP Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Acellular DTP Vaccine Industry Trends
  2. 2.2 Acellular DTP Vaccine Industry Drivers
  3. 2.3 Acellular DTP Vaccine Industry Opportunities and Challenges
  4. 2.4 Acellular DTP Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Acellular DTP Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Acellular DTP Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Acellular DTP Vaccine Price (2021-2026)
  4. 3.4 Global Acellular DTP Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Acellular DTP Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Acellular DTP Vaccine Company, Product Type & Application
  7. 3.7 Global Acellular DTP Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Acellular DTP Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Acellular DTP Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Acellular DTP Vaccine Tier 1, Tier 2, and Tier 3
4 Acellular DTP Vaccine Regional Status and Outlook
  1. 4.1 Global Acellular DTP Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Acellular DTP Vaccine Historic Market Size by Region
  3. 4.2.1 Global Acellular DTP Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Acellular DTP Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Acellular DTP Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Acellular DTP Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Acellular DTP Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Acellular DTP Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Acellular DTP Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Acellular DTP Vaccine by Application
  1. 5.1 Acellular DTP Vaccine Market by Application
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.2 Global Acellular DTP Vaccine Market Size by Application
  5. 5.2.1 Global Acellular DTP Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Acellular DTP Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Acellular DTP Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Acellular DTP Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Acellular DTP Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Acellular DTP Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Acellular DTP Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Acellular DTP Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AJ Vaccines
  2. 6.1.1 AJ Vaccines Company Information
  3. 6.1.2 AJ Vaccines Business Overview
  4. 6.1.3 AJ Vaccines Acellular DTP Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AJ Vaccines Acellular DTP Vaccine Product Portfolio
  6. 6.1.5 AJ Vaccines Recent Developments
  7. 6.2 GSK
  8. 6.2.1 GSK Company Information
  9. 6.2.2 GSK Business Overview
  10. 6.2.3 GSK Acellular DTP Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GSK Acellular DTP Vaccine Product Portfolio
  12. 6.2.5 GSK Recent Developments
  13. 6.3 Panacea Biotec
  14. 6.3.1 Panacea Biotec Company Information
  15. 6.3.2 Panacea Biotec Business Overview
  16. 6.3.3 Panacea Biotec Acellular DTP Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Panacea Biotec Acellular DTP Vaccine Product Portfolio
  18. 6.3.5 Panacea Biotec Recent Developments
  19. 6.4 Sanofi
  20. 6.4.1 Sanofi Company Information
  21. 6.4.2 Sanofi Business Overview
  22. 6.4.3 Sanofi Acellular DTP Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sanofi Acellular DTP Vaccine Product Portfolio
  24. 6.4.5 Sanofi Recent Developments
  25. 6.5 Hualan Biological Vaccine
  26. 6.5.1 Hualan Biological Vaccine Company Information
  27. 6.5.2 Hualan Biological Vaccine Business Overview
  28. 6.5.3 Hualan Biological Vaccine Acellular DTP Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hualan Biological Vaccine Acellular DTP Vaccine Product Portfolio
  30. 6.5.5 Hualan Biological Vaccine Recent Developments
  31. 6.6 BioKangtai
  32. 6.6.1 BioKangtai Company Information
  33. 6.6.2 BioKangtai Business Overview
  34. 6.6.3 BioKangtai Acellular DTP Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 BioKangtai Acellular DTP Vaccine Product Portfolio
  36. 6.6.5 BioKangtai Recent Developments
  37. 6.7 CanSino Biologics
  38. 6.7.1 CanSino Biologics Company Information
  39. 6.7.2 CanSino Biologics Business Overview
  40. 6.7.3 CanSino Biologics Acellular DTP Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 CanSino Biologics Acellular DTP Vaccine Product Portfolio
  42. 6.7.5 CanSino Biologics Recent Developments
  43. 6.8 Walvax Biotechnology
  44. 6.8.1 Walvax Biotechnology Company Information
  45. 6.8.2 Walvax Biotechnology Business Overview
  46. 6.8.3 Walvax Biotechnology Acellular DTP Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Walvax Biotechnology Acellular DTP Vaccine Product Portfolio
  48. 6.8.5 Walvax Biotechnology Recent Developments
  49. 6.9 CNBG
  50. 6.9.1 CNBG Company Information
  51. 6.9.2 CNBG Business Overview
  52. 6.9.3 CNBG Acellular DTP Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 CNBG Acellular DTP Vaccine Product Portfolio
  54. 6.9.5 CNBG Recent Developments
7 North America by Country
  1. 7.1 North America Acellular DTP Vaccine Sales by Country
  2. 7.1.1 North America Acellular DTP Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Acellular DTP Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Acellular DTP Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Acellular DTP Vaccine Market Size by Country
  6. 7.2.1 North America Acellular DTP Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Acellular DTP Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Acellular DTP Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Acellular DTP Vaccine Sales by Country
  2. 8.1.1 Europe Acellular DTP Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Acellular DTP Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Acellular DTP Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Acellular DTP Vaccine Market Size by Country
  6. 8.2.1 Europe Acellular DTP Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Acellular DTP Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Acellular DTP Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Acellular DTP Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Acellular DTP Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Acellular DTP Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Acellular DTP Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Acellular DTP Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Acellular DTP Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Acellular DTP Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Acellular DTP Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Acellular DTP Vaccine Sales by Country
  2. 10.1.1 South America Acellular DTP Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Acellular DTP Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Acellular DTP Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Acellular DTP Vaccine Market Size by Country
  6. 10.2.1 South America Acellular DTP Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Acellular DTP Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Acellular DTP Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Acellular DTP Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Acellular DTP Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Acellular DTP Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Acellular DTP Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Acellular DTP Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Acellular DTP Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Acellular DTP Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Acellular DTP Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Acellular DTP Vaccine Value Chain Analysis
  2. 12.1.1 Acellular DTP Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Acellular DTP Vaccine Production Mode & Process
  7. 12.2 Acellular DTP Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Acellular DTP Vaccine Distributors
  10. 12.2.3 Acellular DTP Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst